Sorafenib in Thyroid Cancer Patients: Learning From Toxicity

被引：3
|
作者：
Huillard, Olivier [1 ]
Blanchet, Benoit [2 ]
Boudou-Rouquette, Pascaline [1 ]
Thomas-Schoemann, Audrey [2 ,3 ]
Wassermann, Johanna [4 ]
Goldwasser, Francois [1 ]
机构：
[1] Paris Descartes Univ, Cochin Hosp, AP HP, Dept Med Oncol,Angiogenesis Inhibitors Multidisci, Paris, France
[2] Paris Descartes Univ, Cochin Hosp, AP HP, Pharmacokinet & Pharmacochem Unit,Angiogenesis In, Paris, France
[3] Paris Descartes Univ, Fac Pharm, Paris Pharmaceut Res Ctr, CNRS,UMR 8638, Paris, France
[4] Univ Paris 06, Pitie Salpetriere Hosp, AP HP, Dept Med Oncol, Paris, France
来源：
ONCOLOGIST | 2014年 / 19卷 / 08期
关键词：
D O I：
10.1634/theoncologist.2014-0156
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E3 / E3
页数：1
相关论文
共 50 条
  • [1] Sorafenib in Thyroid Cancer Patients: Learning From Toxicity In Reply
    Cabanillas, Maria E.
    Dadu, Ramona
    Lai, Stephen Y.
    ONCOLOGIST, 2014, 19 (08): : E4 - E4
  • [2] Sorafenib for patients with differentiated thyroid cancer
    Lee, Hyo Jin
    Ryu, Hyewon
    Choi, Yoon Seok
    Song, Ik-Chan
    Yun, Hwan-Jung
    Jo, Deog-Yeon
    Kim, Samyong
    LANCET, 2015, 385 (9964): : 228 - 228
  • [3] Sorafenib and Thyroid Cancer
    Fallahi, Poupak
    Ferrari, Silvia Martina
    Santini, Francesca
    Corrado, Alda
    Materazzi, Gabriele
    Ulisse, Salvatore
    Miccoli, Paolo
    Antonelli, Alessandro
    BIODRUGS, 2013, 27 (06) : 615 - 628
  • [4] Sorafenib and thyroid cancer
    Park, Chandler
    Perini, Jessica
    Farmer, Roger W.
    Fancy, Tanya
    Monga, Manish
    Remick, Scot C.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2014, 9 (06) : 561 - 570
  • [5] Sorafenib and Thyroid Cancer
    Poupak Fallahi
    Silvia Martina Ferrari
    Francesca Santini
    Alda Corrado
    Gabriele Materazzi
    Salvatore Ulisse
    Paolo Miccoli
    Alessandro Antonelli
    BioDrugs, 2013, 27 : 615 - 628
  • [6] Sorafenib in the treatment of thyroid cancer
    Ferrari, Silvia Martina
    Politti, Ugo
    Spisni, Roberto
    Materazzi, Gabriele
    Baldini, Enke
    Ulisse, Salvatore
    Miccoli, Paolo
    Antonelli, Alessandro
    Fallahi, Poupak
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (08) : 863 - 874
  • [7] Sorafenib in metastatic thyroid cancer
    Capdevila, Jaume
    Iglesias, Lara
    Halperin, Irene
    Segura, Angel
    Martinez-Trufero, Javier
    Angeles Vaz, Maria
    Corral, Jesus
    Obiols, Gabriel
    Grande, Enrique
    Jose Grau, Juan
    Tabernero, Josep
    ENDOCRINE-RELATED CANCER, 2012, 19 (02) : 209 - 216
  • [8] Sorafenib (Nexavar) for Thyroid Cancer
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2014, 56 (1443): : 43 - 44
  • [9] Experience of sorafenib treatment in differentiated thyroid cancer from Taiwan
    Lin, Chen-Yuan
    Chang, Jeffrey S.
    Huang, Shih-Ming
    Hung, Chung-Jye
    Hung, Chien-Ling
    Chang, Chwen-Tzuei
    Yang, Horng-Ren
    Hsieh, Te-Chun
    Huang, Yu-Hui
    Tsai, Hui-Jen
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2021, 120 (01) : 189 - 195
  • [10] Action of thyroid hormones in sorafenib treatment of thyroid cancer
    Campos Haedo, Mateo N.
    Diaz Flaque, Maria C.
    Sterle, Helena A.
    Diaz Albuja, Johanna A.
    Cayrol, Maria F.
    Debernardi, Maria M.
    Perona, Marina
    Juvenal, Guillermo J.
    Cremaschi, Graciela A.
    Rosemblit, Cinthia
    CANCER RESEARCH, 2023, 83 (07)
12345